VOYA Investment Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.86M | Buy |
59,465
+11,400
| +24% | +$357K | ﹤0.01% | 1336 |
|
2025
Q1 | $1.61M | Sell |
48,065
-14,350
| -23% | -$481K | ﹤0.01% | 1389 |
|
2024
Q4 | $2.45M | Buy |
62,415
+15,250
| +32% | +$598K | ﹤0.01% | 1230 |
|
2024
Q3 | $1.86M | Hold |
47,165
| – | – | ﹤0.01% | 1361 |
|
2024
Q2 | $1.84M | Sell |
47,165
-17,775
| -27% | -$693K | ﹤0.01% | 1341 |
|
2024
Q1 | $2.8M | Hold |
64,940
| – | – | ﹤0.01% | 1212 |
|
2023
Q4 | $2.99M | Sell |
64,940
-2,200
| -3% | -$101K | ﹤0.01% | 1202 |
|
2023
Q3 | $2.29M | Hold |
67,140
| – | – | ﹤0.01% | 1278 |
|
2023
Q2 | $2.58M | Hold |
67,140
| – | – | ﹤0.01% | 1245 |
|
2023
Q1 | $2.4M | Hold |
67,140
| – | – | ﹤0.01% | 1280 |
|
2022
Q4 | $2.65M | Hold |
67,140
| – | – | ﹤0.01% | 1229 |
|
2022
Q3 | $2.42M | Buy |
+67,140
| New | +$2.42M | ﹤0.01% | 1242 |
|